Article
Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
American journal of hematology - 1 Jul 2005
Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A, Hongeng S
Abstract excerpt
The involvement of phase I and II enzymes is well documented in the metabolism of a wide range of drugs and xenobiotics. Single-nucleotide polymorphisms (SNPs) of these enzymes are also known to alter their protein expression and function. Moreover, genetic susceptibility and environmental exposure have been proposed to be an etiology of cancer. We hypothesized that polymorphisms of these enzymes might affect the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
